Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin

Detalles Bibliográficos
Autores principales: Qu, Yang, Xia, Peng, Zhang, Shanyong, Pan, Su, Zhao, Jianwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600422/
https://www.ncbi.nlm.nih.gov/pubmed/34726252
http://dx.doi.org/10.3892/or.2021.8213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600422/
https://www.ncbi.nlm.nih.gov/pubmed/34726252
http://dx.doi.org/10.3892/or.2021.8213

Ejemplares similares